Pages that link to "Q44717361"
Jump to navigation
Jump to search
The following pages link to Quantification of 5,6-dihydrouracil by HPLC-electrospray tandem mass spectrometry (Q44717361):
Displaying 12 items.
- beta-Ureidopropionase deficiency: an inborn error of pyrimidine degradation associated with neurological abnormalities (Q28115518) (← links)
- Clinical, biochemical and molecular analysis of 13 Japanese patients with β-ureidopropionase deficiency demonstrates high prevalence of the c.977G > A (p.R326Q) mutation [corrected]. (Q34151650) (← links)
- LC-MS/MS method for simultaneous analysis of uracil, 5,6-dihydrouracil, 5-fluorouracil and 5-fluoro-5,6-dihydrouracil in human plasma for therapeutic drug monitoring and toxicity prediction in cancer patients (Q34210342) (← links)
- Altered Pre-mRNA Splicing Caused by a Novel Intronic Mutation c.1443+5G>A in the Dihydropyrimidinase (DPYS) Gene (Q35895211) (← links)
- Evaluation of an oral uracil loading test to identify DPD-deficient patients using a limited sampling strategy (Q36618144) (← links)
- Evidence for endogenous formation of the hepatocarcinogen N-nitrosodihydrouracil in rats treated with dihydrouracil and sodium nitrite: a potential source of human hepatic DNA carboxyethylation (Q37339901) (← links)
- Analysis of severely affected patients with dihydropyrimidine dehydrogenase deficiency reveals large intragenic rearrangements of DPYD and a de novo interstitial deletion del(1)(p13.3p21.3). (Q45782171) (← links)
- Beta-ureidopropionase deficiency presenting with febrile status epilepticus (Q46897484) (← links)
- Beta-ureidopropionase deficiency presenting with congenital anomalies of the urogenital and colorectal systems (Q46928078) (← links)
- Dihydropyrimidinase deficiency in four East Asian patients due to novel and rare DPYS mutations affecting protein structural integrity and catalytic activity (Q47622401) (← links)
- Identification of a novel synonymous mutation in the human β -Ureidopropionase Gene UPB1 affecting pre-mRNA splicing (Q48805691) (← links)
- Capecitabine-based treatment of a patient with a novel DPYD genotype and complete dihydropyrimidine dehydrogenase deficiency. (Q50000993) (← links)